KYMERA THERAPEUTICS I
43.04
08-10月-24 15:59:58
15 分の遅延
株式
+0.83
+1.97%
本日の幅
42.41 - 43.90
ISIN
N/A
ソース
NASDAQ
-
14 12 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Provides Webcast Information for December 14 Investor Event
01 12 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Third Quarter 2022 Financial Results and Provides a Business Update
03 11 2022 07:05:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Appoints Biopharmaceutical Leader Victor Sandor, M.D.C.M., to Board of Directors
03 11 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Third Quarter 2022 Results on November 3
20 10 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
13 10 2022 16:15:00 提供 Nasdaq GlobeNewswire
-
15 9 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Participate in Upcoming September Conferences
29 8 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Kymera Announces $150 Million Private Placement Equity Financing
19 8 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Business Update
09 8 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Second Quarter 2022 Results on August 9
27 7 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
08 7 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
01 6 2022 08:42:40 提供 Nasdaq GlobeNewswire
-
01 6 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update
03 5 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
19 4 2022 08:00:02 提供 Nasdaq GlobeNewswire